Quality of Life and Pain in Advanced Stage Prostate Cancer: Results of a Southwest Oncology Group Randomized Trial Comparing Docetaxel and Estramustine to Mitoxantrone and Predniso... von BERRY, Donna L, MOINPOUR, Carol M, HUSSAIN, Maha H. A, CRAWFORD, E. David, JIANG, Caroline S, ANKERST, Donna Pauler, PETRYLAK, Daniel P, VINSON, Lynne V, LARA, Primo N, JONES, Sharon, TAPLIN, Mary E, BURCH, Patrick A

Volltext

Phase 2 Study of Neoadjuvant Docetaxel Plus Bevacizumab in Patients With High-Risk Localized Prostate Cancer: A Prostate Cancer Clinical Trials Consortium Trial von ROSS, Robert W, GALSKY, Matthew D, TEMPANY, Clare M, KANTOFF, Philip W, TAPLIN, Mary E, OH, William K, FEBBO, Phil, BARRY, Marc, RICHIE, Jerome P, WANLING XIE, FENNESSY, Fiona M, BHATT, Rupal S, HAYES, Julia, CHOUEIRI, Toni K

Volltext

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high‐risk localized prostate cancer von Ross, Robert W., Galsky, Matthew D., Febbo, Phil, Barry, Marc, Richie, Jerome P., Xie, Wanling, Fennessy, Fiona M., Bhatt, Rupal S., Hayes, Julia, Choueiri, Toni K., Tempany, Clare M., Kantoff, Philip W., Taplin, Mary E., Oh, William K.

Volltext

Phase II Study of Neoadjuvant Chemotherapy with Docetaxel and Bevacizumab in Patients with High-Risk Localized Prostate Cancer: A Prostate Cancer Clinical Trials Consortium Trial von Ross, Robert W, Galsky, Matthew D, Febbo, Phil, Barry, Marc, Richie, Jerome P, Xie, Wanling, Fennessy, Fiona M, Bhatt, Rupal, Hayes, Julia, Choueiri, Toni K, Tempany, Clare M, Taplin, Mary E, Oh, William K

Volltext

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy von Scher, Howard I, Fizazi, Karim, Saad, Fred, Taplin, Mary-Ellen, Sternberg, Cora N, Miller, Kurt, de Wit, Ronald, Mulders, Peter, Chi, Kim N, Shore, Neal D, Armstrong, Andrew J, Flaig, Thomas W, Fléchon, Aude, Mainwaring, Paul, Fleming, Mark, Hainsworth, John D, Hirmand, Mohammad, Selby, Bryan, Seely, Lynn, de Bono, Johann S

Volltext

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall surviv... von Ryan, Charles J, Prof, Smith, Matthew R, Prof, Fizazi, Karim, Prof, Saad, Fred, Prof, Mulders, Peter F A, Prof, Sternberg, Cora N, MD, Miller, Kurt, Prof, Logothetis, Christopher J, Prof, Shore, Neal D, MD, Small, Eric J, Prof, Carles, Joan, MD, Flaig, Thomas W, MD, Taplin, Mary-Ellen, MD, Higano, Celestia S, Prof, de Souza, Paul, Prof, de Bono, Johann S, Prof, Griffin, Thomas W, MD, De Porre, Peter, MD, Yu, Margaret K, MD, Park, Youn C, PhD, Li, Jinhui, PhD, Kheoh, Thian, PhD, Naini, Vahid, PharmD, Molina, Arturo, MD, Rathkopf, Dana E, MD

Volltext

Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer von Mendes, Adrianna A., Lu, Jiayun, Kaur, Harsimar B., Zheng, Siqun L., Xu, Jianfeng, Hicks, Jessica, Weiner, Adam B., Schaeffer, Edward M., Ross, Ashley E., Balk, Steven P., Taplin, Mary‐Ellen, Lack, Nathan A., Tekoglu, Emirhan, Maynard, Janielle P., De Marzo, Angelo M., Antonarakis, Emmanuel S., Sfanos, Karen S., Joshu, Corinne E., Shenderov, Eugene, Lotan, Tamara L.

Volltext

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy von Ryan, Charles J, Smith, Matthew R, de Bono, Johann S, Molina, Arturo, Logothetis, Christopher J, de Souza, Paul, Fizazi, Karim, Mainwaring, Paul, Piulats, Josep M, Ng, Siobhan, Carles, Joan, Mulders, Peter F.A, Basch, Ethan, Small, Eric J, Saad, Fred, Schrijvers, Dirk, Van Poppel, Hendrik, Mukherjee, Som D, Suttmann, Henrik, Gerritsen, Winald R, Flaig, Thomas W, George, Daniel J, Yu, Evan Y, Efstathiou, Eleni, Pantuck, Allan, Winquist, Eric, Higano, Celestia S, Taplin, Mary-Ellen, Park, Youn, Kheoh, Thian, Griffin, Thomas, Scher, Howard I, Rathkopf, Dana E

Volltext

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study von Scher, Howard I, Prof, Beer, Tomasz M, MD, Higano, Celestia S, MD, Anand, Aseem, MA, Taplin, Mary-Ellen, MD, Efstathiou, Eleni, MD, Rathkopf, Dana, MD, Shelkey, Julia, BS, Yu, Evan Y, MD, Alumkal, Joshi, MD, Hung, David, MD, Hirmand, Mohammad, MD, Seely, Lynn, MD, Morris, Michael J, MD, Danila, Daniel C, MD, Humm, John, PhD, Larson, Steve, MD, Fleisher, Martin, PhD, Sawyers, Charles L, MD

Volltext

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 von Scher, Howard I, Morris, Michael J, Stadler, Walter M, Higano, Celestia, Basch, Ethan, Fizazi, Karim, Antonarakis, Emmanuel S, Beer, Tomasz M, Carducci, Michael A, Chi, Kim N, Corn, Paul G, de Bono, Johann S, Dreicer, Robert, George, Daniel J, Heath, Elisabeth I, Hussain, Maha, Kelly, Wm Kevin, Liu, Glenn, Logothetis, Christopher, Nanus, David, Stein, Mark N, Rathkopf, Dana E, Slovin, Susan F, Ryan, Charles J, Sartor, Oliver, Small, Eric J, Smith, Matthew Raymond, Sternberg, Cora N, Taplin, Mary-Ellen, Wilding, George, Nelson, Peter S, Schwartz, Lawrence H, Halabi, Susan, Kantoff, Philip W, Armstrong, Andrew J

Volltext

Neoadjuvant Enzalutamide Prior to Prostatectomy von Montgomery, Bruce, Tretiakova, Maria S, Joshua, Anthony M, Gleave, Martin E, Fleshner, Neil, Bubley, Glenn J, Mostaghel, Elahe A, Chi, Kim N, Lin, Daniel W, Sanda, Martin, Novotny, William, Wu, Kenneth, Kantoff, Philip W, Marck, Brett T, Plymate, Stephen, Balk, Steven P, Nelson, Peter S, Matsumoto, Alvin M, Lis, Rosina T, Kibel, Adam, Haas, Gabriel P, Krivoshik, Andrew, Hannah, Alison, Taplin, Mary-Ellen

Volltext

Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302) von Rathkopf, Dana E, Smith, Matthew R, de Bono, Johann S, Logothetis, Christopher J, Shore, Neal D, de Souza, Paul, Fizazi, Karim, Mulders, Peter F.A, Mainwaring, Paul, Hainsworth, John D, Beer, Tomasz M, North, Scott, Fradet, Yves, Van Poppel, Hendrik, Carles, Joan, Flaig, Thomas W, Efstathiou, Eleni, Yu, Evan Y, Higano, Celestia S, Taplin, Mary-Ellen, Griffin, Thomas W, Todd, Mary B, Yu, Margaret K, Park, Youn C, Kheoh, Thian, Small, Eric J, Scher, Howard I, Molina, Arturo, Ryan, Charles J, Saad, Fred

Volltext

Genetic testing in prostate cancer management: Considerations informing primary care von Giri, Veda N., Morgan, Todd M., Morris, David S., Berchuck, Jacob E., Hyatt, Colette, Taplin, Mary‐Ellen

Volltext

Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence von Taplin, Mary-Ellen, Balk, Steven P.

Volltext

Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer von Mahal, Brandon A., Yang, David D., Wang, Natalie Q., Alshalalfa, Mohammed, Davicioni, Elai, Choeurng, Voleak, Schaeffer, Edward M., Ross, Ashley E., Spratt, Daniel E., Den, Robert B., Martin, Neil E., Mouw, Kent W., Orio, Peter F., Choueiri, Toni K., Taplin, Mary-Ellen, Trinh, Quoc-Dien, Feng, Felix Y., Nguyen, Paul L.

Volltext

Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer von Su, Christopher T., Nizialek, Emily, Berchuck, Jacob E., Vlachostergios, Panagiotis J., Ashkar, Ryan, Sokolova, Alexandra, Barata, Pedro C., Aggarwal, Rahul R., McKay, Rana R., Agarwal, Neeraj, McClure, Heather M., Nafissi, Nellie, Bryce, Alan H., Sartor, Oliver, Sayegh, Nicolas, Cheng, Heather H., Adra, Nabil, Sternberg, Cora N., Taplin, Mary‐Ellen, Cieslik, Marcin, Alva, Ajjai S., Antonarakis, Emmanuel S.

Volltext

Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer von Berchuck, Jacob E., Zhang, Zhenwei, Silver, Rebecca, Kwak, Lucia, Xie, Wanling, Lee, Gwo-Shu Mary, Freedman, Matthew L., Kibel, Adam S., Van Allen, Eliezer M., McKay, Rana R., Taplin, Mary-Ellen

Volltext

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer von Zhang, Zeda, Karthaus, Wouter R., Lee, Young Sun, Gao, Vianne R., Wu, Chao, Russo, Joshua W., Liu, Menghan, Mota, Jose Mauricio, Abida, Wassim, Linton, Eliot, Lee, Eugine, Barnes, Spencer D., Chen, Hsuan-An, Mao, Ninghui, Wongvipat, John, Choi, Danielle, Chen, Xiaoping, Zhao, Huiyong, Manova-Todorova, Katia, de Stanchina, Elisa, Taplin, Mary-Ellen, Balk, Steven P., Rathkopf, Dana E., Gopalan, Anuradha, Carver, Brett S., Mu, Ping, Jiang, Xuejun, Watson, Philip A., Sawyers, Charles L.

Volltext

Insulin resistance during androgen deprivation therapy in men with prostate cancer von Basaria, Shehzad, Taplin, Mary‐Ellen, McDonnell, Marie, Simonson, Donald C., Lin, Alexander P., Dufour, Alyssa B., Habtemariam, Daniel, Nguyen, Paul L., Ravi, Praful, Kibel, Adam S., Sweeney, Christopher J., D’Amico, Anthony V., Roberts, Daniel A., Xu, Wenxin, Wei, Xiao X., Sunkara, Rajitha, Choudhury, Atish D., Mantia, Charlene, Beltran, Himisha, Pomerantz, Mark, Berchuck, Jacob E., Martin, Neil E., Leeman, Jonathan E., Mouw, Kent W., Kilbridge, Kerry E., Bearup, Richelle, Kackley, Hannah, Kafel, Hussein, Huang, Grace, Reid, Kieran F., Storer, Thomas, Braga‐Basaria, Milena, Travison, Thomas G.

Volltext

Introduction: Understanding and Influencing Multilevel Factors Across the Cancer Care Continuum von Taplin, Stephen H., Anhang Price, Rebecca, Edwards, Heather M., Foster, Mary K., Breslau, Erica S., Chollette, Veronica, Prabhu Das, Irene, Clauser, Steven B., Fennell, Mary L., Zapka, Jane

Volltext